YOLFTbeta
XBiotech Inc

XBiotech Inc

XBIT · NASDAQ · Healthcare / Biotechnology

1.96USD+0.00 (0.00%)

Price History

Full chart

Market Stats

Previous Close1.96
Open1.95
Day Range1.95 – 1.99
52-Week Range2.09 – 3.44
Volume105.42K
Market Cap66.46M
P/E (TTM)0.00
Forward P/E0.00
EPS-1.48
Dividend Yield0.00%
Beta0.85
50-Day Avg2.24
200-Day Avg2.37

About

XBiotech Inc., a biopharmaceutical company, discovers, and develops, True Human monoclonal antibodies for treating various diseases. It develops a pipeline of product candidates targeting inflammatory and infectious diseases. The company is also developing interleukin-1 alpha therapies to various medical conditions, such as cancer, stroke, heart attack, or arthritis; and mediates tissue breakdown, angiogenesis, the formation of blood clots, malaise, muscle wasting, and general inflammation. The company was incorporated in 2005 and is headquartered in Austin, Texas.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEODr. Sushma Shivaswamy Ph.D.
  • Employees87
  • Headquarters5217 Winnebago Lane, Austin, TX, United States, 78744, USA
  • Websitehttps://www.xbiotech.com

Leadership

  • Mr. John SimardFounder & Chairman · b. 1962
  • Dr. Sushma Shivaswamy Ph.D.Interim CEO & Chief Scientific Officer · b. 1978
  • Ms. Angela HuDirector of Finance · b. 1984
  • Dr. Qian WuSenior Vice President of Clinical Operations & Analytical Quality

Financials

Income Statement

Currency: USD2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue--0000012.68M44.00M18.39M4.01M300.00K00
Growth (%)--------+246.95%-58.19%-78.20%-92.52%-100.00%-
Cost of Revenue946.00K784.00K664.00K699.00K698.00K1.48M2.43M2.36M34.55M5.82M651.00K1.74M1.75M1.69M
Gross Profit-946.00K-784.00K-664.00K-699.00K-698.00K-1.48M-2.43M-2.36M9.45M12.57M3.36M-1.74M--1.69M
Gross Margin--------18.62%21.48%68.36%83.77%-581.33%--
Operating Expense14.22M9.14M21.11M36.81M52.06M32.58M18.56M28.87M27.73M37.66M37.85M35.77M-54.00M
Operating Income-15.16M-9.93M-21.78M-37.51M-52.76M-34.06M-20.99M-31.23M-18.28M-25.08M-34.49M-37.51M-42.47M-55.69M
Operating Margin--------246.30%-41.54%-136.36%-860.10%-12503.33%--
EBITDA-14.21M-9.14M-21.11M-36.81M-52.06M-32.58M-18.70M720.81M-16.04M-22.81M-30.97M-22.57M-36.01M-43.53M
EBITDA Margin-------5684.20%-36.45%-124.01%-772.42%-7523.00%--
Net Income-15.16M-9.93M-21.72M-37.48M-52.76M-33.15M-21.14M668.63M-11.22M-17.41M-32.90M-24.56M-38.53M-45.54M
Net Income Margin-------5272.68%-25.50%-94.67%-820.45%-8185.67%--
R&D13.33M7.93M14.33M31.31M42.49M26.42M15.72M24.09M9.53M28.27M31.54M32.85M37.76M47.39M
R&D as % of Total Revenue-------189.97%21.65%153.68%786.63%10949.33%--
Interest Expense0000000748.80M8.95M1.09M902.00K0807.00K88.00K
Interest Expense % of Total Revenue-------5904.88%20.33%5.91%22.49%0.00%--

Balance Sheet

Currency: USD2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets8.47M11.07M62.18M109.36M67.05M62.97M44.34M816.88M353.74M275.18M246.10M226.62M199.09M150.08M
Total Liabilities1.10M845.00K3.15M6.31M7.99M2.81M2.95M61.25M5.11M5.79M5.70M7.77M16.82M9.73M
Total Equity7.37M10.23M59.03M103.05M59.06M60.16M41.40M755.63M348.64M269.38M240.40M218.85M182.27M140.35M
Cash4.17M7.24M57.33M91.05M34.32M31.77M15.82M714.59M237.37M236.98M157.31M200.02M172.68M125.55M
Total Debt1.00K-----------10.25M-
Net Debt-4.17M-7.24M-57.33M-91.05M-34.32M-31.77M-15.82M-714.59M-237.37M-236.98M-157.31M-200.02M-162.43M-125.55M

Cash Flow

Currency: USD2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-11.63M-8.91M-11.70M-33.31M-46.02M-33.65M-16.54M-18.27M-65.15M69.44M-14.82M-18.73M-30.96M-39.92M
Investing Cash Flow-550.00K-59.00K-1.40M-10.39M-13.91M-1.41M-122.00K674.80M-3.73M-3.52M-63.89M61.50M-1.30M-289.00K
Financing Cash Flow7.28M12.04M63.20M77.47M2.94M33.32M201.00K42.10M-409.72M-67.01M33.00K-9.00K10.45M-10.25M
Capital Expenditure550.00K59.00K1.40M10.39M13.91M1.41M122.00K204.00K3.73M3.52M585.00K362.00K1.30M289.00K
Free Cash Flow-12.18M-8.97M-13.10M-43.70M-59.93M-35.05M-16.66M-18.47M-68.88M65.92M-15.41M-19.09M-32.27M-40.21M
Dividends Paid---00075.00M75.00M75.00M75.00M0---
FCF to OCF104.73%100.66%111.94%131.20%130.24%104.18%100.74%101.12%105.72%94.92%103.95%101.93%104.21%100.72%
Dividend Paid to FCF---0.00%0.00%0.00%-450.23%-405.99%-108.90%113.78%0.00%---

Earnings

Report DateMay 27, 2015Aug 14, 2015Nov 13, 2015Mar 30, 2016May 13, 2016Aug 12, 2016Nov 14, 2016Mar 16, 2017May 10, 2017Aug 8, 2017Nov 9, 2017Mar 16, 2018May 8, 2018Aug 9, 2018Oct 31, 2018Mar 14, 2019May 9, 2019Aug 9, 2019Nov 12, 2019Mar 16, 2020May 11, 2020Aug 10, 2020Nov 9, 2020Mar 16, 2021May 12, 2021Aug 13, 2021Nov 11, 2021Mar 2, 2022May 11, 2022Aug 9, 2022Nov 9, 2022Mar 15, 2023May 10, 2023Aug 11, 2023Nov 9, 2023Mar 15, 2024May 10, 2024Aug 12, 2024Nov 7, 2024Mar 13, 2025May 8, 2025Aug 29, 2025Nov 28, 2025Feb 25, 2026Mar 31, 2026Aug 13, 2026Nov 11, 2026
EPS Estimate---0.21-0.35-0.39-0.35-0.46-0.42-0.47-0.47-0.47-0.47-0.11-0.16-0.14-0.17-0.16-0.15-0.15-0.150.060.040.040.040.040.030.030.02-------------0.000.000.00---
EPS Actual-0.29-0.22-0.33-0.38-0.32-0.42-0.38-0.51-0.32-0.32-0.18-0.22-0.32-0.32-0.32-0.17-0.16-0.16-0.1514.590.06-0.09-0.09-0.06-0.06-0.06-0.11-0.06-0.18-0.38-0.42-0.11-0.13-0.29-0.24-0.15-0.33-0.43-0.16-0.34-0.36-0.06-0.20-0.88-0.18-0.22-
Surprise---57.14%-8.57%17.95%-20.00%17.39%-21.43%31.91%31.91%61.70%53.19%-190.91%-100.00%-128.57%0.00%0.00%-6.67%0.00%9826.67%0.00%-317.50%-325.00%-250.00%-250.00%-300.00%-466.67%-400.00%-------------------
TimingAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hours-----After-hoursPre-marketAfter-hoursAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-market------

Key Statistics & Ratios

Market Cap66.46M
Enterprise Value-95.96M
Trailing P/E0.00
Forward P/E0.00
PEG Ratio0.00
Price / Sales12.23
Price / Book0.52
EPS-1.48
Book Value4.21
Revenue (TTM)300.00K
Gross Profit (TTM)3.36M
EBITDA-46.78M
Profit Margin0.00%
Operating Margin0.00%
Return on Equity-29.94%
Return on Assets-19.30%
Shares Outstanding30.49M
Shares Float22.84M
Beta0.85
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Ownership Breakdown

Institutions
6.73%
Insiders
24.33%
Retail / Other
68.94%

Top Institutional Holders

  • BlackRock Inc
    293.10K0.96%
  • Geode Capital Management, LLC
    231.02K0.76%
  • Vanguard Capital Management, LLC
    200.97K0.66%
  • RBF LLC
    198.50K0.65%
  • Morgan Stanley - Brokerage Accounts
    165.55K0.54%
  • Bridgeway Capital Management, LLC
    98.45K0.32%
  • Vanguard Fiduciary Trust Co
    91.58K0.30%
  • Millennium Management LLC
    79.33K0.26%
  • Northern Trust Corp
    76.09K0.25%
  • State Street Corp
    73.01K0.24%
  • Jane Street Group LLC
    60.10K0.20%
  • Empowered Funds, LLC
    59.55K0.20%
  • Squarepoint Ops LLC
    41.21K0.14%
  • Bank of New York Mellon Corp
    39.35K0.13%
  • Bank of America Corp
    36.69K0.12%
  • Dimensional Fund Advisors, Inc.
    36.05K0.12%

Top Fund Holders

  • Fidelity Extended Market Index
    94.74K0.31%
  • iShares Micro-Cap ETF
    78.07K0.26%
  • EA Bridgeway Omni Small-Cap Value ETF
    59.55K0.20%
  • Bridgeway Ultra-Small Company
    38.90K0.13%

Dividends

20211×
2.50Jul 15, 2021